Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America.

Zhou J, Jaquet A, Bissagnene E, Musick B, Wools-Kaloustian K, Maxwell N, Boulle A, Wehbe F, Masys D, Iriondo-Perez J, Hemingway-Foday J, Law M; Western Africa, Eastern Africa, Southern Africa, Caribbean and Central and South America, and Asia Pacific Regions of the International Epidemiologic Databases to Evaluate AIDS-IeDEA..

J Int AIDS Soc. 2012 Jan 30;15(1):5. doi: 10.1186/1758-2652-15-5.

2.

Distribution of HIV-1 plasma RNA viral load and CD4 + T-cell counts among HIV-infected Africans evaluated for antiretroviral therapy.

Nkengasong JN, Borget MY, Maurice C, Boateng E, Kalou M, Djomand G, Ekpini R, Eholie S, Bissagene E, Coulibaly M, Wiktor SZ, Roels TH, Chorba T.

J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):99-101. No abstract available.

PMID:
11579285
3.

High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire.

Adjé C, Cheingsong R, Roels TH, Maurice C, Djomand G, Verbiest W, Hertogs K, Larder B, Monga B, Peeters M, Eholie S, Bissagene E, Coulibaly M, Respess R, Wiktor SZ, Chorba T, Nkengasong JN; UNAIDS HIV Drug Access Initiative, Abidjan, Côte d'Ivoire..

J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):501-6.

PMID:
11391173

Supplemental Content

Loading ...
Support Center